SPRY Therapeutics Secures $15 Million in Funding to Revolutionize Healthcare with Innovative Soft-Surface Filter Technology

SPRY Therapeutics is thrilled to announce that it has successfully raised $15 million in its latest funding round. This significant investment underscores the growing confidence in SPRY’s innovative approach to health technology, particularly its groundbreaking proprietary soft-surface filter technology. Designed to block all pathogens from entering or exiting any soft surface it’s applied to, SPRY’s solution is set to revolutionize patient care environments. With this funding, the company is poised to enhance its offerings, providing effective, sustainable alternatives to traditional healthcare products such as pillows, positioners, boots, and wedges. As healthcare facilities increasingly prioritize both patient and caregiver safety alongside environmental sustainability, SPRY Therapeutics aims to facilitate these goals by significantly reducing carbon emissions associated with healthcare materials. The new capital will be allocated toward the expansion of product development, allowing SPRY to advance its research initiatives and bring its novel technologies to more hospitals and care centers. Moreover, the funding will bolster SPRY’s marketing efforts, ensuring that healthcare professionals are aware of the transformative benefits of its products. By integrating health improvements with environmental responsibility, SPRY Therapeutics is not just shaping the future of healthcare equipment, but also contributing to a more sustainable planet. This fundraising achievement marks an exciting milestone for SPRY, enabling the company to push forward in its mission to deliver safer, greener solutions to the healthcare industry.